Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy
Article first published online: 23 JAN 2011
© 2011 Japanese Cancer Association
Volume 102, Issue 3, pages 639–647, March 2011
How to Cite
Amamoto, R., Yagi, M., Song, Y., Oda, Y., Tsuneyoshi, M., Naito, S., Yokomizo, A., Kuroiwa, K., Tokunaga, S., Kato, S., Hiura, H., Samori, T., Kang, D. and Uchiumi, T. (2011), Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy. Cancer Science, 102: 639–647. doi: 10.1111/j.1349-7006.2010.01828.x
- Issue published online: 17 FEB 2011
- Article first published online: 23 JAN 2011
- Accepted manuscript online: 9 DEC 2010 08:14AM EST
- (Received August 9, 2010/Revised December 1, 2010/Accepted December 2, 2010/Accepted manuscript online December 9, 2010/Article first published online January 23, 2011)
Table S1. Clinicopathological parameters in 148 patients with prostate cancer.
Table S2. Relationship between the expression of p32 and Gleason score, EPE.
Fig. S1. Immunohistochemical staining of prostate cancer with purified monoclonal p32 antibodies result in cytoplasm reactivity.
Fig. S2. Growth retardation after androgen deprivation in LNCaP cell (*P < 0.05 vs androgen withdrawal).
|CAS_1828_sm_Supp-Fig-1.tif||5705K||Supporting info item|
|CAS_1828_sm_Supp-FIg-2.tif||641K||Supporting info item|
|CAS_1828_sm_Supp-Table-1-2.doc||59K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.